Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Effects of physical activity on systemic oxidative/DNA status in breast cancer survivors.

Tomasello B, Malfa GA, Strazzanti A, Gangi S, Di Giacomo C, Basile F, Renis M.

Oncol Lett. 2017 Jan;13(1):441-448. doi: 10.3892/ol.2016.5449.

2.

Pre and post radiotherapy serum oxidant/antioxidant status in breast cancer patients: Impact of age, BMI and clinical stage of the disease.

Khalil Arjmandi M, Moslemi D, Sadati Zarrini A, Ebrahimnezhad Gorji M, Mosapour A, Haghhaghighi A, Halalkhor S, Bijani A, Parsian H.

Rep Pract Oncol Radiother. 2016 May-Jun;21(3):141-8. doi: 10.1016/j.rpor.2015.12.009.

PMID:
27601942
3.

The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.

Wolf TJ, Doherty M, Kallogjeri D, Coalson RS, Nicklaus J, Ma CX, Schlaggar BL, Piccirillo J.

Oncology. 2016;91(3):143-52. doi: 10.1159/000447744.

PMID:
27449501
4.

[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.

Laforest R, Lapi SE, Oyama R, Bose R, Tabchy A, Marquez-Nostra BV, Burkemper J, Wright BD, Frye J, Frye S, Siegel BA, Dehdashti F.

Mol Imaging Biol. 2016 Dec;18(6):952-959.

PMID:
27146421
5.

The status of antioxidants, malondialdehyde and some trace elements in serum of patients with breast cancer.

Sadati Zarrini A, Moslemi D, Parsian H, Vessal M, Mosapour A, Shirkhani Kelagari Z.

Caspian J Intern Med. 2016 Winter;7(1):31-6.

6.

Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.

Frasier LL, Holden S, Holden T, Schumacher JR, Leverson G, Anderson B, Greenberg CC, Neuman HB.

JAMA Oncol. 2016 Jan;2(1):95-101. doi: 10.1001/jamaoncol.2015.3717. Erratum in: JAMA Oncol. 2016 Jan;2(1):146.

7.

Management of Malignant Pericardial Effusion.

Petrofsky M.

J Adv Pract Oncol. 2014 Jul-Aug;5(4):281-9. Review. No abstract available.

8.

A Case Report of Male Occult Breast Cancer First Manifesting as Axillary Lymph Node Metastasis With Part of Metastatic Mucinous Carcinoma.

He M, Liu H, Jiang Y.

Medicine (Baltimore). 2015 Jun;94(25):e1038. doi: 10.1097/MD.0000000000001038.

9.

Predictors for contralateral prophylactic mastectomy in breast cancer patients.

Fu Y, Zhuang Z, Dewing M, Apple S, Chang H.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3748-64.

10.

Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result.

Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ.

J Community Support Oncol. 2015 May;13(5):195-201. doi: 10.12788/jcso.0135. No abstract available.

11.

Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.

Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH.

Ann Surg Oncol. 2015 Dec;22(13):4263-9. doi: 10.1245/s10434-015-4552-x.

12.

Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.

Kim W, Chung Y, Kim SH, Park S, Bae JH, Kim G, Lee SJ, Kim JE, Park BW, Lim SK, Rhee Y.

Endocrinol Metab (Seoul). 2015 Mar 27;30(1):58-64. doi: 10.3803/EnM.2015.30.1.58.

13.

Multi-state models for investigating possible stages leading to bipolar disorder.

Keown-Stoneman CD, Horrocks J, Darlington GA, Goodday S, Grof P, Duffy A.

Int J Bipolar Disord. 2015 Feb 24;3:5. doi: 10.1186/s40345-014-0019-4.

14.

ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.

Li JW, Mo M, Yu KD, Chen CM, Hu Z, Hou YF, Di GH, Wu J, Shen ZZ, Shao ZM, Liu GY.

PLoS One. 2014 Dec 11;9(12):e114646. doi: 10.1371/journal.pone.0114646.

15.

Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy.

Lee CN, Wetschler MH, Chang Y, Belkora JK, Moy B, Partridge A, Sepucha KR.

BMC Med Inform Decis Mak. 2014 Aug 20;14:73. doi: 10.1186/1472-6947-14-73.

16.

Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancer.

Pan C, Hu Y, Li J, Wang Z, Huang J, Zhang S, Ding L.

PLoS One. 2014 Aug 15;9(8):e104459. doi: 10.1371/journal.pone.0104459.

17.

Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy.

Meattini I, Cecchini S, Di Cataldo V, Saieva C, Francolini G, Scotti V, Bonomo P, Mangoni M, Greto D, Nori J, Orzalesi L, Casella D, Simoncini R, Fambrini M, Bianchi S, Livi L.

Biomed Res Int. 2014;2014:719175. doi: 10.1155/2014/719175.

18.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators.; International Breast Cancer Study Group..

N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037.

19.

Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer.

Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, Hortobagyi GN, Smith BD, Giordano SH.

J Clin Oncol. 2014 Jul 1;32(19):2010-7. doi: 10.1200/JCO.2013.49.3676.

20.

Current approaches and challenges in early detection of breast cancer recurrence.

Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF.

J Cancer. 2014 Mar 16;5(4):281-90. doi: 10.7150/jca.8016. Review.

Items per page

Supplemental Content

Support Center